Company / Goodwill
NEKTAR THERAPEUTICS Goodwill History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$76.5M
FY2023
5-year range
$76.5M / $76.5M
FY2019-FY2023
Trend
+0.0%
vs FY2022
Sector context
#41 of 75
Health Care
What the data says
At $77M, NEKTAR THERAPEUTICS's goodwill ranks #41 of 75 in the Health Care sector. Goodwill remained relatively stable over the past 8 years, with values between $77M and $77M.
Based on SEC 10-K filings.
$77M in FY2023 with a 5-year CAGR of +0.0%.
Remained stable around $77M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
#41 of 75 in Health CareTop 55% of 75This company $76.5M Sector average $4.0B
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2023, goodwill increased 0.0% year-over-year.
- Ranks #41 out of 75 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $76.5M | +0.0% |
| FY2022 | $76.5M | +0.0% |
| FY2021 | $76.5M | +0.0% |
| FY2020 | $76.5M | +0.0% |
| FY2019 | $76.5M | +0.0% |
| FY2018 | $76.5M | +0.0% |
| FY2017 | $76.5M | +0.0% |
| FY2016 | $76.5M | +0.0% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026